FTSE 100
|
9 698,37
|
-109,31
|
-1,11 %
|
Analysen zu FTSE 100-Werten
| 11.11.24 | Rolls-Royce Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | International Consolidated Airlines Hold | Deutsche Bank AG | |
| 08.11.24 | National Grid Buy | Deutsche Bank AG | |
| 08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | International Consolidated Airlines Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | International Consolidated Airlines Neutral | UBS AG | |
| 08.11.24 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 08.11.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.11.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 07.11.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 07.11.24 | National Grid Buy | UBS AG | |
| 07.11.24 | Rolls-Royce Buy | UBS AG | |
| 07.11.24 | National Grid Outperform | RBC Capital Markets | |
| 07.11.24 | AstraZeneca Sell | UBS AG | |
| 07.11.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 07.11.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.24 | Rolls-Royce Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 05.11.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 05.11.24 | easyJet Overweight | Morgan Stanley | |
| 05.11.24 | International Consolidated Airlines Overweight | Morgan Stanley | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | BP Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | Shell Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 04.11.24 | AstraZeneca Sell | UBS AG | |
| 04.11.24 | Unilever Halten | DZ BANK | |
| 04.11.24 | Shell Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 04.11.24 | Rolls-Royce Buy | Goldman Sachs Group Inc. | |
| 04.11.24 | Rolls-Royce Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | Reckitt Benckiser Market-Perform | Bernstein Research | |
| 01.11.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 01.11.24 | Reckitt Benckiser Hold | Jefferies & Company Inc. | |
| 01.11.24 | Reckitt Benckiser Outperform | RBC Capital Markets |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.